{"id":12576,"date":"2011-01-01T00:00:00","date_gmt":"2011-01-01T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/uncategorized\/show061\/"},"modified":"2011-01-01T00:00:00","modified_gmt":"2011-01-01T00:00:00","slug":"show061","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/talk\/show061\/","title":{"rendered":"Univadis – Merck’s Online Source for Medical Education in Europe"},"content":{"rendered":"

Univadis Merck’s Online Source for Medical Education in EuropeClick Here for Additional Resources<\/a><\/p>\n

A conversation with Dr. Ina Weisshardt<\/b>, recently employed by MSD (Merck & Co.), discusses the educational partnership between univadis — MSD’s physician portal — and the BMJ group to role-out a truly pan-European physician educational platform.<\/p>\n

Aired LIVE on: <\/p>\n

Thursday, November, 6, 2008<\/b> <\/p>\nBackground<\/b><\/p>\n

We all have read in the news about Pfizer in the US and its decision not to back CME courses provided by for-profit, third-party companies but only courses developed by academia and universities (see “Pfizer to stop funding for-profit CME<\/a>“). Also other companies are evaluating new approaches through collaborations with independent organizations or through separation of their educational departments within the orgnization as well as through collaoration with web 2.0 physician communities (eg, Pfizer and Sermo; see “Pfizer has a Gold Mine in Sermo!<\/a>“).<\/p>\n

While at MSD, Weisshardt set up the objective to increase physicians value through providing access to unbiased health information and medical education as a not-for-profit service based on an identified need for physicians. One “tool” for this was the launch of MSD’s medical platform “univadis”, a unique international initiative with local presence and adaptation to local needs.<\/p>\nQuestions\/Topics Discussed<\/b> <\/p>\n